drugset / Trial / NCT03326050

Comparison Between Rifampicin and Gemifloxacin and Ciprofloxacin in Treatment of Rhinoscleroma

NCT03326050

Phase 0 Unknown 60 enrolled Assiut University
RandomizedParallel-groupOpen-labelTreatment

Summary

gemifloxacin versus ciprofloxacin and rifampicin in treatment of rhinoscleroma

Timeline

Start
2018-02
Primary completion
2018-09-01
Completion
2018-10

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Ciprofloxacin Small molecule 750 mg Oral
Comparator Gemifloxacin Small molecule 320 mg Oral
Comparator Rifampin Small molecule 150 mg
Comparator Rifampin Small molecule 300 mg

Indications